"Clubbing" of the fingers is a classic features of Cystic Fibrosis, although not present in many patients. Credit: Jerry Nick, M.D./ Wikipedia
Many people with cystic fibrosis develop diabetes. The reasons for this have been largely unknown, but now researchers at Lund University in Sweden and Karolinska institutet have identified a molecular mechanism that contributes to the raised diabetes risk.
"The increased risk of diabetes has previously been explained by the fact that cystic fibrosis causes damage to the pancreas, where the blood-sugar regulating hormone insulin is produced. We are the first research group to show that the mutated gene that causes cystic fibrosis also plays an important role in the release of insulin. The risk of diabetes is not only explained by the destruction of the pancreas", said Anna Edlund, a doctoral student at Lund University Diabetes Centre.
Cystic fibrosis is the result of a genetic mutation in an ion channel that normally regulates salt transport in cells, primarily in the lungs and pancreas. The mutation leads to a wide variety of symptoms. Individuals with cystic fibrosis produce a lot of thick, viscous mucus. This makes their airways sensitive to infection, and repeated or chronic lung infections are common. The secretion of pancreatic juice from the pancreas to the intestine is hindered, which causes diarrhoea and poor weight gain.
Left untreated, cystic fibrosis is fatal, but with improved treatment of symptoms, survival has improved. Many people with cystic fibrosis now live beyond the age of 40.
"Cystic Fibrosis is a severe health condition and diabetes exacerbates an already problematic situation", said Malin Flodström-Tullberg, a researcher at the Centre for Infectious Medicine, Karolinska institutet.
Many people with cystic fibrosis have poor sugar metabolism. At the age of 30, around one in four people with cystic fibrosis also has diabetes that requires treatment with insulin. What the researchers have now shown is that the mutation in the cystic fibrosis gene inhibits the secretion of insulin into the blood, which means that the level is insufficient when the demands on the insulin increase, such as after a meal.
"Normally, insulin is released in two stages. The early stage is a rapid response to raised blood sugar and the later stage aims to restore blood sugar levels. In cystic fibrosis, the early stage of insulin release in particular is insufficient", said Anna Edlund, adding:
"Our results also correspond to clinical observations. Many patients with cystic fibrosis who do not have diabetes have normal blood sugar in a fasting state, but raised blood sugar after a meal."
The researchers have worked on insulin producing cells from mice and deceased donors. They have shown that the cystic fibrosis gene plays an important role in the complex chain of events that precedes the release of insulin.
When the cells were exposed to high glucose levels, they responded as expected by increasing insulin secretion, but when a preparation that specifically obstructs the ion channel expressed by the cystic fibrosis gene was added, the cells' ability to release insulin fell significantly.
"Despite being common among cystic fibrosis patients, surprisingly little is known about the mechanisms behind diabetes in this group of individuals. We
need to know what causes the problem in order to develop preventive treatments that improve the cells' ability to secrete insulin. Our study provide a first
piece of increased understanding how CFTR contribute to insulin secretion", said Lena Eliasson, Professor at Lund University Diabetes Centre.
Explore further: Novel drug target linked to insulin secretion and type 2 diabetes treatment
More information: Anna Edlund, Jonathan LS Esguerra, Anna Wendt, Malin Flodström-Tullberg and Lena Eliasson. "CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells." BMC Medicine. DOI: 10.1186/1741-7015-12-87
Medical Xpress on facebook
Related Stories
Inhaler approved for cystic fibrosis patients
Mar 25, 2013
(HealthDay)—The TOBI Podhaler (tobramycin inhalation powder) has been approved by the U.S. Food and Drug Administration to treat cystic fibrosis patients infected with Pseudomonas aeruginosa, a bacterium that can damage ...
Novel drug target linked to insulin secretion and type 2 diabetes treatment
May 26, 2014
A signal that promotes insulin secretion and reduces hyperglycemia in a type 2 diabetes animal model is enhanced by the inhibition of a novel enzyme discovered by CHUM Research Centre (CRCHUM) and University of Montreal researchers. ...
New test for cystic fibrosis may lead to more treatments
Feb 12, 2014
(Medical Xpress)—Treatments for cystic fibrosis may be easier to develop with the use of a new test created by Stanford researchers.
Cystic fibrosis disrupts pancreas two ways in CF-related diabetes
Sep 17, 2012
A new University of Iowa study suggests there are two root causes of a type of diabetes associated with cystic fibrosis (CF). The findings, which already have sparked a clinical trial, may guide development ...
New proteins to clear the airways in cystic fibrosis and COPD
Jul 13, 2012
University of North Carolina scientists have uncovered a new strategy that may one day help people with cystic fibrosis and chronic obstructive pulmonary disorder better clear the thick and sticky mucus that clogs their lungs ...
Recommended for you
Discovery of protein that regulates cellular recycling yields new drug targets
57 minutes ago
Researchers at the University of Michigan have discovered a key regulator of autophagy, the cellular recycling process involved in many human diseases. The finding illuminates potential new drug targets for cancer, neurodegeneration ...
Paired enzyme action in yeast reveals backup system for DNA repair
19 hours ago
The combined action of two enzymes, Srs2 and Exo1, prevents and repairs common genetic mutations in growing yeast cells, according to a new study led by scientists at NYU Langone Medical Center.
Coaxing iPS cells to become more specialized prior to transplantation cuts rejection risk
May 30, 2014
For many scientists, the clinical promise of stem cells has been dampened by very real concerns that the immune system will reject the transplanted cells before they could render any long-term benefit. Previous research in ...
New test measuring cell bioenergetic health could become key tool in personalized medicine
May 30, 2014
Researchers at the University of Alabama at BirminghamSchool of Medicine have created an experimental blood test that, for the first time, determines a "Bioenergetic Health Index," or BHI, by gauging the ...
New 3-D representation of Richard III's spine shows 'spiral nature' of his scoliosis
May 29, 2014
Shakespeare may have characterised Richard III as a hunchback, but now everyone can explore the true shape of one of history's most famous spinal columns.
Study shows how misfolded proteins are selected for disposal
May 29, 2014
It's almost axiomatic that misfolded proteins compromise how cells normally function and cause debilitating human disease, but how these proteins are detected and degraded within the body is not well understood. ...
User comments
© Medical Xpress 2011-2014, Science X network
"Clubbing" of the fingers is a classic features of Cystic Fibrosis, although not present in many patients. Credit: Jerry Nick, M.D./ Wikipedia
Many people with cystic fibrosis develop diabetes. The reasons for this have been largely unknown, but now researchers at Lund University in Sweden and Karolinska institutet have identified a molecular mechanism that contributes to the raised diabetes risk.
"The increased risk of diabetes has previously been explained by the fact that cystic fibrosis causes damage to the pancreas, where the blood-sugar regulating hormone insulin is produced. We are the first research group to show that the mutated gene that causes cystic fibrosis also plays an important role in the release of insulin. The risk of diabetes is not only explained by the destruction of the pancreas", said Anna Edlund, a doctoral student at Lund University Diabetes Centre.
Cystic fibrosis is the result of a genetic mutation in an ion channel that normally regulates salt transport in cells, primarily in the lungs and pancreas. The mutation leads to a wide variety of symptoms. Individuals with cystic fibrosis produce a lot of thick, viscous mucus. This makes their airways sensitive to infection, and repeated or chronic lung infections are common. The secretion of pancreatic juice from the pancreas to the intestine is hindered, which causes diarrhoea and poor weight gain.
Left untreated, cystic fibrosis is fatal, but with improved treatment of symptoms, survival has improved. Many people with cystic fibrosis now live beyond the age of 40.
"Cystic Fibrosis is a severe health condition and diabetes exacerbates an already problematic situation", said Malin Flodström-Tullberg, a researcher at the Centre for Infectious Medicine, Karolinska institutet.
Many people with cystic fibrosis have poor sugar metabolism. At the age of 30, around one in four people with cystic fibrosis also has diabetes that requires treatment with insulin. What the researchers have now shown is that the mutation in the cystic fibrosis gene inhibits the secretion of insulin into the blood, which means that the level is insufficient when the demands on the insulin increase, such as after a meal.
"Normally, insulin is released in two stages. The early stage is a rapid response to raised blood sugar and the later stage aims to restore blood sugar levels. In cystic fibrosis, the early stage of insulin release in particular is insufficient", said Anna Edlund, adding:
"Our results also correspond to clinical observations. Many patients with cystic fibrosis who do not have diabetes have normal blood sugar in a fasting state, but raised blood sugar after a meal."
The researchers have worked on insulin producing cells from mice and deceased donors. They have shown that the cystic fibrosis gene plays an important role in the complex chain of events that precedes the release of insulin.
When the cells were exposed to high glucose levels, they responded as expected by increasing insulin secretion, but when a preparation that specifically obstructs the ion channel expressed by the cystic fibrosis gene was added, the cells' ability to release insulin fell significantly.
"Despite being common among cystic fibrosis patients, surprisingly little is known about the mechanisms behind diabetes in this group of individuals. We
need to know what causes the problem in order to develop preventive treatments that improve the cells' ability to secrete insulin. Our study provide a first
piece of increased understanding how CFTR contribute to insulin secretion", said Lena Eliasson, Professor at Lund University Diabetes Centre.
Explore further: Novel drug target linked to insulin secretion and type 2 diabetes treatment
More information: Anna Edlund, Jonathan LS Esguerra, Anna Wendt, Malin Flodström-Tullberg and Lena Eliasson. "CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells." BMC Medicine. DOI: 10.1186/1741-7015-12-87
Medical Xpress on facebook
Related Stories
Inhaler approved for cystic fibrosis patients
Mar 25, 2013
(HealthDay)—The TOBI Podhaler (tobramycin inhalation powder) has been approved by the U.S. Food and Drug Administration to treat cystic fibrosis patients infected with Pseudomonas aeruginosa, a bacterium that can damage ...
Novel drug target linked to insulin secretion and type 2 diabetes treatment
May 26, 2014
A signal that promotes insulin secretion and reduces hyperglycemia in a type 2 diabetes animal model is enhanced by the inhibition of a novel enzyme discovered by CHUM Research Centre (CRCHUM) and University of Montreal researchers. ...
New test for cystic fibrosis may lead to more treatments
Feb 12, 2014
(Medical Xpress)—Treatments for cystic fibrosis may be easier to develop with the use of a new test created by Stanford researchers.
Cystic fibrosis disrupts pancreas two ways in CF-related diabetes
Sep 17, 2012
A new University of Iowa study suggests there are two root causes of a type of diabetes associated with cystic fibrosis (CF). The findings, which already have sparked a clinical trial, may guide development ...
New proteins to clear the airways in cystic fibrosis and COPD
Jul 13, 2012
University of North Carolina scientists have uncovered a new strategy that may one day help people with cystic fibrosis and chronic obstructive pulmonary disorder better clear the thick and sticky mucus that clogs their lungs ...
Recommended for you
Discovery of protein that regulates cellular recycling yields new drug targets
57 minutes ago
Researchers at the University of Michigan have discovered a key regulator of autophagy, the cellular recycling process involved in many human diseases. The finding illuminates potential new drug targets for cancer, neurodegeneration ...
Paired enzyme action in yeast reveals backup system for DNA repair
19 hours ago
The combined action of two enzymes, Srs2 and Exo1, prevents and repairs common genetic mutations in growing yeast cells, according to a new study led by scientists at NYU Langone Medical Center.
Coaxing iPS cells to become more specialized prior to transplantation cuts rejection risk
May 30, 2014
For many scientists, the clinical promise of stem cells has been dampened by very real concerns that the immune system will reject the transplanted cells before they could render any long-term benefit. Previous research in ...
New test measuring cell bioenergetic health could become key tool in personalized medicine
May 30, 2014
Researchers at the University of Alabama at BirminghamSchool of Medicine have created an experimental blood test that, for the first time, determines a "Bioenergetic Health Index," or BHI, by gauging the ...
New 3-D representation of Richard III's spine shows 'spiral nature' of his scoliosis
May 29, 2014
Shakespeare may have characterised Richard III as a hunchback, but now everyone can explore the true shape of one of history's most famous spinal columns.
Study shows how misfolded proteins are selected for disposal
May 29, 2014
It's almost axiomatic that misfolded proteins compromise how cells normally function and cause debilitating human disease, but how these proteins are detected and degraded within the body is not well understood. ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment